Delivery Order SPE2DB22D1202-SPE2DB24FUMY6
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a $1,890.63 order for the pharmaceutical product Trileptal 300 mg/5 ml suspension. The contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,800.81, is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. This is a firm fixed-price delivery order contract with a period of performance through May 30, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The contract is a firm-fixed price delivery order with a ceiling value of $1,099.02 and a period of performance through March 22, 2023. AmerisourceBergen is the prime contractor, and there is no indication of any set-aside requirements for this award. This contract is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.59 Firm Fixed Price Delivery Order, with a completion date of March 1, 2023, is for the supply of 4560094860 - TRILEPTAL 300 MG/5 ML SUSP 250ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.25 Firm Fixed Price Delivery Order is for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $7,223.90 firm fixed-price delivery order is for the supply of 250 ml bottles of the drug Trileptal, a medication used to treat certain types of seizures. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,079.45 firm-fixed-price delivery order is for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,851.90 by the Defense Logistics Agency (DLA) on January 9, 2026, for the supply of Trileptal 300 mg/5 mL suspension in 250 mL quantities. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by January 12, 2026, with the product being delivered to Conshohocken, Pennsylvania, where the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The firm-fixed-price delivery order has a ceiling value of $1,281.54 and an ultimate completion date of January 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The contract is not designated as a set-aside....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the supply of Trileptal 300 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $10,177.84 and an ultimate completion date of September 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a major pharmaceutical distribution company serving the U.S. federal government, particularly the...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUMY6Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,067.99 firm fixed-price contract is for the supply of Trileptal 300 mg/5 ml suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award represents a specific delivery order against that larger IDC. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, with no major subcontractors listed. This contract supports the DLA's mission of providing medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/19/24 |